Vedolizumab for Ulcerative Colitis and Crohn’s Disease: Results and Implications of GEMINI Studies
Mindy Lam(Vancouver Coastal Health), Brian Bressler(University of British Columbia)
Cited by 43
Related Papers
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
|New England Journal of Medicine|2013|2.7k
Rates of New or Missed Colorectal Cancers After Colonoscopy and Their Risk Factors: A Population-Based Analysis
|Gastroenterology|2007|627
The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in Pregnancy
|Gastroenterology|2015|478